DEVICE · Unmapped registry intervention
SAPIEN 3 THV
Find medicine records ·
Find other trials using this name
Clinical trial
Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
NCT02661451
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BIOLOGICAL · Unmapped registry intervention
Optimal Heart Failure Therapy
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedTranscatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
SAPIEN 3 THVDEVICE
Optimal Heart Failure TherapyBIOLOGICAL
Sponsors & collaborators
Cardiovascular Research Foundation, New Yorklead sponsor
Cardialysis BVcollaborator
Avaniacollaborator
Mapped research locations
MilwaukeeWisconsin, United States3New YorkNew York, United States2BostonMassachusetts, United States2ChicagoIllinois, United States2Los AngelesCalifornia, United States2PhiladelphiaPennsylvania, United States1St LouisMissouri, United States1MiamiFlorida, United States1TorontoOntario, Canada1NashvilleTennessee, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02661451 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.